A Closer Look at Access to Essential Medicines in South Sudan

By Staff Writer

January 7, 2024

The Crucial Role of Medicines in Healthcare

When it comes to medical care and access to essential medicines in South Sudan, medicines are an essential component. Essential medicines play a crucial role in reducing morbidity and mortality rates from acute and chronic diseases. Meeting the United Nations’ Sustainable Development Goals (SDGs) requires comprehensive research and policy implementation to ensure easy access to these medicines. A global commitment is necessary to address gaps in healthcare access and pharmaceutical supply chains. This commitment will support the World Health Organization’s goal of achieving 80% availability by 2025. A human right is the right to have access to medications that are safe, effective, of high quality, and inexpensive. The reality, however, is very different from this ideal in many low- and middle-income countries (LMICs), where access to medicines is frequently hindered by issues such as a lack of availability and an unaffordable price.

The Status Quo in South Sudan

Despite its efforts to boost its healthcare system since gaining independence, South Sudan faces numerous issues. Protracted violence, poverty, inefficient pharmaceutical supply management, an inadequately skilled workforce, lack of infrastructure, and climate change effects impede progress. The country has set up the Emergency Medications Fund (EMF) to improve the provision of essential drugs and high-quality medical services. The South Sudan Ministry of Health and other organisations collaborated to develop this fund. But difficulties still exist, particularly with regard to gaining access to essential medicines in South Sudan.

Investigating Medicine Prices, Availability, and Affordability

Researchers conducted a study in Juba County, South Sudan, to determine the pricing, availability, and affordability of essential drugs. They aimed to gauge the progress of the nation in enhancing the accessibility and affordability of its medical facilities. The study revealed inadequate availability of pharmaceuticals across all investigated sectors. The public sector showed an average availability of only 50.4%. The study found only 0.07% of the examined drugs affordable, declaring the majority as unaffordable due to high pricing.

Perspectives on the Future and Recommendations

The findings of the study on access to essential medicines in South Sudan led to the formulation of a number of conclusions and suggestions. Among these are the implementation of regulations that regulate prices, particularly in the private sector, the enhancement of funds for the health sector, and the expansion of the availability of medicines in the public sector. These findings can serve as substantial evidence for policymakers to use when formulating policies that will limit prices, boost the supply of medicines and make them more affordable, strengthen the public health system, and reorganise the pharmaceutical sector in South Sudan.

Reference url

Recent Posts

Argentina WHO Withdrawal
   

Argentina WHO Withdrawal: President Milei Exits Global Health Alliance Amid COVID-19 Disputes

💡 *What happens when a country decides to withdraw from global health organizations?*
Argentina’s President Javier Milei has made the bold move to withdraw from the WHO, citing significant disagreements over health management during the pandemic. This decision raises questions about national sovereignty, cooperation, and the future of global health initiatives. Dive into the implications of Argentina’s stance and what it means for international health governance.

#SyenzaNews #globalhealth #healthcarepolicy

Gauteng HPV vaccination campaign
      

Gauteng HPV Vaccination Campaign: Protecting Girls Against Cervical Cancer

💉 Ready to protect our future generations from cervical cancer?

The Gauteng HPV vaccination campaign aims to vaccinate grade 5, 6, and 7 girls against the virus that causes most cervical cancers. By leveraging a single-dose regimen, this initiative not only enhances access to life-saving vaccines but also strives to meet ambitious global health targets.

Explore how this campaign is reshaping health outcomes in South Africa and why parental consent is key to its success.

#SyenzaNews #HealthEconomics #HealthcareInnovation #UniversalHealthCoverage

Capvaxive vaccine approval
     

Capvaxive Vaccine Approval

🌍 What if a single vaccine could significantly change the landscape of pneumococcal disease prevention in adults?

The European Medicines Agency has just recommended Merck’s Capvaxive, an innovative 21-valent pneumococcal conjugate vaccine! With robust data from multiple phase 3 trials, this potential approval marks a pivotal step in the fight against invasive Streptococcus pneumoniae infections in the EU. Look into how Capvaxive could enhance public health outcomes and offer extensive serotype coverage.

#SyenzaNews #pharmaceuticals #healthcarepolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.